EMA ASSESSES USING REMOTE TECHNOLOGY TO STAGE CLINICAL TRIALS
September 1st, 2011
BY KEITH NUTHALL
THE EUROPEAN Medicines Agency (EMA) is reviewing the European Union (EU) guidelines regarding the use of remote telephone and Internet systems in clinical trials. EMA wants input from the pharmaceutical sector about the management of medicine expiry dates in trials using these systems, as well as handling unblinding, dose change and other considerations. See
http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2011/08/WC500110227.pdf
ENDS
THE EUROPEAN Medicines Agency (EMA) is reviewing the European Union (EU) guidelines regarding the use of remote telephone and Internet systems in clinical trials. EMA wants input from the pharmaceutical sector about the management of medicine expiry dates in trials using these systems, as well as handling unblinding, dose change and other considerations. See
http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2011/08/WC500110227.pdf
ENDS
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.